Duvelisib: New Treatment for Relapse Refractory CLL - 100004

Spotlight
Video

Duvelisib: New Treatment for Relapse Refractory CLL

imedex has 1284 videos Subscribe Here

Loading........
Description: Jennifer Brown, M.D., Director of the CLL Center of the Division of Hematologic Malignancies at Dana-Farber Cancer Institute and an Associate Professor of Medicine at Harvard Medical School in Boston, Massachusetts discusses Duvelisib: New Treatment For Relapse Refractory CLL at Lymphoma & Myeloma on October 18, 2018.
Shared By : imedex
Posted on : 11/28/18
Added : 11 days ago